TERAPIA COMBINADA PARA A FIBROSE QUÍSTICA

• 收藏
• 分享

专利权人:

I.E.R.F.C. EUROPEAN INSTITUTE FOR CYSTIC FIBROSIS RESEARCH

发明人:

LUIGI MAIURI,VALERIA RAIA,FABIO BORELLA,GUIDO KROEMER

申请号：

PT12168409

公开号：

PT2664326T

申请日:

2012.05.17

申请国别(地区):

PT

年份:

2018

代理人:

摘要：

There is disclosed a combination of inhibitors of Tissue Transglutaminase (TG2), inhibitors of reactive oxygen species (ROS) and CFTR channel activators (potentiators) for separate, sequential or simultaneous administration to CF patients carrying the ”F508-CFTR mutation, and pharmaceutical compositions thereof.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/